STOCK TITAN

Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Tenon Medical (NASDAQ: TNON), a company focused on Sacroiliac Joint (SIJ) disorders treatment, has scheduled its Q3 2024 financial results release for November 13, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day, featuring a Q&A session with covering analysts. The call will be accessible via phone (1-800-717-1738 US, 1-646-307-1865 International) and webcast. A replay will be available through November 27, 2024, via the company's IR website or telephone.

Tenon Medical (NASDAQ: TNON), un'azienda specializzata nel trattamento dei disturbi dell'articolazione sacroiliaca (SIJ), ha programmato la pubblicazione dei suoi risultati finanziari per il terzo trimestre del 2024 per il 13 novembre 2024, dopo la chiusura del mercato. L'azienda organizzerà una conferenza telefonica alle 16:30 ora orientale dello stesso giorno, con una sessione di domande e risposte con analisti di settore. La chiamata sarà accessibile tramite telefono (1-800-717-1738 US, 1-646-307-1865 Internazionale) e in streaming. Una registrazione sarà disponibile fino al 27 novembre 2024, tramite il sito web IR dell'azienda o telefono.

Tenon Medical (NASDAQ: TNON), una empresa centrada en el tratamiento de trastornos de la articulación sacroilíaca (SIJ), ha programado la publicación de sus resultados financieros del tercer trimestre de 2024 para el 13 de noviembre de 2024, después del cierre del mercado. La empresa realizará una llamada de conferencia a las 4:30 p.m. hora del Este el mismo día, con una sesión de preguntas y respuestas con analistas destacados. La llamada será accesible por teléfono (1-800-717-1738 EE. UU., 1-646-307-1865 Internacional) y por webcast. Una repetición estará disponible hasta el 27 de noviembre de 2024, a través del sitio web de IR de la empresa o por teléfono.

Tenon Medical (NASDAQ: TNON), 천골 관절(SIJ) 장애 치료에 중점을 둔 회사가 2024년 11월 13일 장 마감 후 2024년 3분기 재무 결과 발표를 예정하고 있습니다. 회사는 같은 날 동부 표준시 기준 오후 4시 30분에 Q&A 세션이 포함된 컨퍼런스 콜을 개최할 예정입니다. 이 콜은 전화(1-800-717-1738 미국, 1-646-307-1865 국제) 및 웹캐스트를 통해 접근할 수 있습니다. 녹화 내용은 2024년 11월 27일까지 회사 IR 웹사이트 또는 전화로 이용 가능합니다.

Tenon Medical (NASDAQ: TNON), une entreprise spécialisée dans le traitement des troubles de l'articulation sacro-iliaque (SIJ), a programmé la publication de ses résultats financiers du troisième trimestre 2024 pour le 13 novembre 2024, après la fermeture des marchés. L'entreprise organisera une conférence téléphonique à 16h30, heure de l'Est, le même jour, avec une session de questions-réponses en présence d'analystes. L'appel sera accessible par téléphone (1-800-717-1738 US, 1-646-307-1865 International) et en webdiffusion. Un enregistrement sera disponible jusqu'au 27 novembre 2024, via le site Web des relations investisseurs de l'entreprise ou par téléphone.

Tenon Medical (NASDAQ: TNON), ein auf die Behandlung von Erkrankungen des Iliosakralgelenks (SIJ) spezialisiertes Unternehmen, hat die Veröffentlichung seiner finanziellen Ergebnisse für das 3. Quartal 2024 für den 13. November 2024 nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz mit einer Frage-Antwort-Runde mit Analysten durchführen. Die Teilnahme ist telefonisch (1-800-717-1738 US, 1-646-307-1865 International) sowie via Webcast möglich. Eine Auffrischung wird bis zum 27. November 2024 über die IR-Website des Unternehmens oder telefonisch verfügbar sein.

Positive
  • None.
Negative
  • None.

LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the third quarter 2024 ended September 30, 2024 after market close on Wednesday, November 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Date:

Wednesday, November 13, 2024

Time:

4:30 p.m. Eastern time

Dial-in:

1-800-717-1738

International Dial-in:

1-646-307-1865

Webcast:

TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through November 27, 2024, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 1171684.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.

The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.

Investor Contact

Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.



View the original press release on accesswire.com

FAQ

When will Tenon Medical (TNON) release Q3 2024 earnings?

Tenon Medical will release Q3 2024 financial results on Wednesday, November 13, 2024, after market close.

What time is Tenon Medical's (TNON) Q3 2024 earnings call?

Tenon Medical's Q3 2024 earnings conference call is scheduled for 4:30 p.m. Eastern Time on Wednesday, November 13, 2024.

How can I access Tenon Medical's (TNON) Q3 2024 earnings call?

You can access the call by dialing 1-800-717-1738 (US) or 1-646-307-1865 (International), or via webcast through Tenon's Investor Relations website.

Until when will Tenon Medical's (TNON) Q3 2024 earnings call replay be available?

The earnings call replay will be available through November 27, 2024, via Tenon's IR website or by phone using the access code 1171684.

Tenon Medical, Inc.

NASDAQ:TNON

TNON Rankings

TNON Latest News

TNON Stock Data

8.06M
3.08M
1.7%
1.8%
36.56%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
LOS GATOS